• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Personalis, Inc.

    < Previous 1 2 3 4 Next >
    Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Reports Third Quarter 2023 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis to Announce Third Quarter 2023 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Reports Second Quarter 2023 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis to Participate at Upcoming Investor Conferences
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis to Announce Second Quarter 2023 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Dr. Kenneth J. Widder Joins Personalis Board of Directors
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Reports First Quarter 2023 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis to Announce First Quarter 2023 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Appoints Christopher Hall as Chief Executive Officer
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis Reports Fourth Quarter and Full Year 2022 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis to Announce Fourth Quarter and Full Year 2022 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    Personalis to Participate at Upcoming Investor Conferences
    From Personalis, Inc.
    Via Business Wire
    Tickers PSNL
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.